|
1
|
Prat J: Ovarian carcinomas: Five distinct
diseases with different origins, genetic alterations, and
clinicopathological features. Virchows Archiv. 460:237–249. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Salani R and Bristow RE: Surgical
management of epithelial ovarian cancer. Clin Obstet Gynecol.
55:75–95. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Balkwill F, Charles KA and Mantovani A:
Smoldering and polarized inflammation in the initiation and
promotion of malignant disease. Cancer Cell. 7:211–217. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Loberg RD, Ying C, Craig M, Yan L, Snyder
LA and Pienta KJ: CCL2 as an important mediator of prostate cancer
growth in vivo through the regulation of macrophage infiltration.
Neoplasia. 9:556–562. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qian BZ and Pollard JW: Macrophage
diversity enhances tumor progression and metastasis. Cell.
141:39–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kurahara H, Shinchi H, Mataki Y, Maemura
K, Noma H, Kubo F, Sakoda M, Ueno S, Natsugoe S and Takao S:
Significance of M2-polarized tumor-associated macrophage in
pancreatic cancer. J Surg Res. 167:e211–e219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee CH, Espinosa I, Vrijaldenhoven S,
Subramanian S, Montgomery KD, Zhu S, Marinelli RJ, Peterse JL,
Poulin N, Nielsen TO, et al: Prognostic significance of macrophage
infiltration in leiomyosarcomas. Clin Cancer Res. 14:1423–1430.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shabo I, Stal O, Olsson H, Dore S and
Svanvik J: Breast cancer expression of CD163, a macrophage
scavenger receptor, is related to early distant recurrence and
reduced patient survival. Int J Cancer. 123:780–786. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sica A, Saccani A, Bottazzi B,
Polentarutti N, Vecchi A, van Damme J and Mantovani A: Autocrine
production of IL-10 mediates defective IL-12 production and NF-κB
activation in tumor-associated macrophages. J Immunol. 164:762–767.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lv M, Xiaoping X, Cai H, Li D, Wang J, Fu
X, Yu F, Sun M and Lv Z: Cytokines as prognοstic tool in breast
carcinoma. Front Biosci (Landmark Ed). 16:2515–2526. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sato T, Terai M, Tamura Y, Alexeev V,
Mastrangelo MJ and Selvan SR: Interleukin 10 in the tumor
microenvironment: A target for anticancer immunotherapy. Immunol
Res. 51:170–182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu JY, Li F, Wang LP, Chen XF, Wang D,
Cao L, Ping Y, Zhao S, Li B, Thorne SH, et al: CTL- vs
Treg lymphocyte-attracting chemokines, CCL4 and CCL20,
are strong reciprocal predictive markers for survival of patients
with oesophageal squamous cell carcinoma. Br J Cancer. 113:747–755.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang CY, Qi Y, Li XN, Yang Y, Liu DL,
Zhao J, Zhu DY, Wu K, Zhou XD and Zhao S: The role of CCL20/CCR6
axis in recruiting Treg cells to tumor sites of NSCLC patients.
Biomed Pharmacother. 69:242–248. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen Y, Wei Y, Wang Z, Jing Y, He H, Yuan
J, Li R, Zhao Q, Wei L, Yang T, et al: TGF-β regulates
hepatocellular carcinoma progression by inducing Treg cell
polarization. Cell Physiol Biochem. 35:1623–1632. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma L, Zhang H, Hu K, Lv G, Fu Y, Ayana DA,
Zhao P and Jiang Y: The imbalance between Tregs, Th17 cells and
inflammatory cytokines among renal transplant recipients. BMC
Immunol. 16:562015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peterson RA: Regulatory T-cells: Diverse
phenotypes integral to immune homeostasis and suppression. Toxicol
Pathol. 40:186–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shevach EM and Thornton AM: tTregs,
pTregs, and iTregs: Similarities and differences. Immunol Rev.
259:88–102. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Deavers M, Patenia R, Bassett RL
Jr, Mueller P, Ma Q, Wang E and Freedman RS: Monocyte/macrophage
and T-cell infiltrates in peritoneum of patients with ovarian
cancer or benign pelvic disease. J Transl Med. 4:302006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang C, He L, He P, Liu Y, Wang W, He Y,
Du Y and Gao F: Increased drug resistance in breast cancer by
tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling
pathway. Med Oncol. 32:3522015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mantovani A and Sica A: Macrophages,
innate immunity and cancer: Balance, tolerance, and diversity. Curr
Opin Immunol. 22:231–237. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hanada T, Nakagawa M, Emoto A, Nomura T,
Nasu N and Nomura Y: Prognostic value of tumor-associated
macrophage count in human bladder cancer. Int J Urol. 7:263–269.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fujimoto J, Sakaguchi H, Aoki I and Tamaya
T: Clinical implications of expression of interleukin 8 related to
angiogenesis in uterine cervical cancers. Cancer Res. 60:2632–2635.
2000.PubMed/NCBI
|
|
23
|
Mukhtar RA, Nseyo O, Campbell MJ and
Esserman LJ: Tumor-associated macrophages in breast cancer as
potential biomarkers for new treatments and diagnostics. Expert Rev
Mol Diagn. 11:91–100. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang R, Lu M, Zhang J, Chen S, Luo X, Qin
Y and Chen H: Increased IL-10 mRNA expression in tumor-associated
macrophage correlated with late stage of lung cancer. J Exp Clin
Cancer Res. 30:622011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schmidt A, Oberle N and Krammer PH:
Molecular mechanisms of Treg-mediated T cell suppression. Front
Immunol. 3:512012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao L, Yang J, Wang HP and Liu RY:
Imbalance in the Th17/Treg and cytokine environment in peripheral
blood of patients with adenocarcinoma and squamous cell carcinoma.
Med Oncol. 30:4612013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shigematsu Y, Hanagiri T, Shiota H, Kuroda
K, Baba T, Ichiki Y, Yasuda M, Uramoto H, Takenoyama M, Yasumoto K,
et al: Immunosuppressive effect of regulatory T lymphocytes in lung
cancer, with special reference to their effects on the induction of
autologous tumor-specific cytotoxic T lymphocytes. Oncol Lett.
4:625–630. 2012.PubMed/NCBI
|
|
28
|
Islas-Vazquez L, Prado-Garcia H,
Aguilar-Cazares D, Meneses-Flores M, Galicia-Velasco M,
Romero-Garcia S, Camacho-Mendoza C and Lopez-Gonzalez JS: LAP
TGF-beta subset of CD4+CD25+CD127 Treg cells
is increased and overexpresses LAP TGF-beta in lung adenocarcinoma
patients. BioMed Res Int. 2015:4309432015. View Article : Google Scholar : PubMed/NCBI
|
